Every team member is empowered to make a difference at UCB. Through our culture of collaborative curiosity and commitment to excellence, we support our people in forging their career paths and seizing opportunities to learn and grow. From innovative drug development to inspiring the next generation of scientists, our work is driven by a shared purpose: to make a meaningful impact on patients' lives. Join us in our mission to create value for people living with severe diseases and communities worldwide. Discover how you can make your mark at UCB https://lnkd.in/dHkyid5y #MakeYourMarkForPatients #TeamUCB #PharmaJobs
About us
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology
- Website
-
http://www.ucb.com
External link for UCB
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Brussels
- Type
- Privately Held
- Founded
- 1928
- Specialties
- Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Locations
Employees at UCB
Updates
-
Hear from Christian Wolff, our head of epilepsy discovery research, exploring the underlying disease biology in epilepsies in Drug Discovery Online. #epilepsy #innovation Read more https://lnkd.in/eFk3rB-w
-
Art and music have the power to inspire and connect us all. It’s All Your Fault, Tyler Price! is a musical that tells the moving story of a family’s resilience, strength, and love while caring for someone with #epilepsy. We're proud to sponsor this heartwarming production, premiering in November. Read more:
UCB partners with Ben Decter and Kristin Hanggi on a heartfelt musical about living with epilepsy: It's All Your Fault, Tyler Price!
UCB on LinkedIn
-
At UCB, our work to offer differentiated solutions to more people living with #psoriasis is fueled by collaboration with advocacy groups, HCPs, and the psoriatic disease community. Together, we can make a meaningful difference. #PsoriasisActionMonth https://lnkd.in/e3SfqxX2
-
Although the field of epilepsy research is well-established, we have only just begun to scratch the surface of our understanding of more complex epilepsies. In our latest NeuroInsider series, Liesbeth François, UCB bioinformatician, shares her insights on the molecular hallmarks of epilepsy, and the future of #epilepsy research. Read more: https://lnkd.in/eMCVNHxw #Epilepsy #EpilepsyAwareness #EpilepsySupport
-
Get a glimpse into the world of Biomanufacturing at UCB with Alain Janssens, our Senior Technical and Process Expert. Alain's role involves supporting production activities and ensuring excellence in the production areas. We aim to create a workplace where everyone finds meaning and balance in their careers. Discover more about Alain's journey and how UCB emphasizes collaboration and excellence in daily operations. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers https://lnkd.in/dHkyid5y
-
Rapid and Early Seizure Termination (REST) is an important new concept which advocates for early intervention to avoid the consequences of longer seizures and #seizure emergencies. Find out more here https://lnkd.in/eR5kbeRM
Find out more about REST
-
At UCB, we are committed to #innovation in epilepsy. Hear from Mike Davis about future trends in #epilepsy care. Read more in Clinical Leader https://lnkd.in/euJUzTr6
The Future Of Epilepsy Research And Transformative Treatments
clinicalleader.com
-
The landscape of gene therapy is burgeoning with possibilities, offering promising advancements to patients with genetic disorders. In a revealing conversation with European Pharmaceutical Review Magazine, Roger Palframan, head of U.S. research at UCB, sheds light on the current trends, key developments, and future disruptors in gene therapy. His insights offer a glimpse into the potential of gene therapies. You can read the full interview 👉https://lnkd.in/exhVR3kp
-
At UCB, we measure our progress in access to medicines and continually look at what initiatives we should be working on to improve. Read our CEO Jean-Christophe Tellier's perspective 👇
Yesterday UCB released our Half-Year results. Besides financial and shareholder value, we disclosed our access to medicines indices. The fact that they improved warms my heart - as this shows our real impact: when the patients who need our solutions have access to them and can benefit from their clinical outcomes. Read how we track our progress in equitable access to medicines and what initiatives we are working on. Looking forward to hearing potential new ideas! #Healthcare #Accesstomedicines photo @wutzkoh via Canva.com
Improving Equitable Access to Medicines
Jean-Christophe Tellier on LinkedIn